Cascadian Therapeutics, Inc.

Formerly NASDAQ: CASC

Articles of Incorporation Filter

EX-3.1
from 8-K 1 page Amendment to Company Bylaws Amendment No. 1 to the Bylaws of Cascadian Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Cascadian Therapeutics, Inc. Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 13 pages Cascadian Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series E Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series E Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Cascadian Therapeutics, Inc. Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 13 pages Cascadian Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series D Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series D Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Oncothyreon Inc. Certificate of Amendment to the Amended and Restated Certificate of Incorporation [Remainder of Page Intentionally Left Blank]
12/34/56
EX-3.1
from 8-K 1 page Amended Text of Section 2.8 of the Bylaws of Oncothyreon Inc.: 2.8 Voting
12/34/56
EX-3.1
from 8-K 13 pages Oncothyreon Inc. Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series C Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 12 pages Oncothyreon Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series B Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 12 pages Oncothyreon Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law Series a Convertible Preferred Stock
12/34/56
EX-3.1
from 8-K 2 pages Oncothyreon Inc. Certificate of Amendment to the Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 10-Q 26 pages Bylaws of Oncothyreon Inc
12/34/56
EX-3.1
from 8-K 1 page Text of Amendments to the Bylaws of Oncothyreon Inc. Effective June 12, 2009
12/34/56
EX-3.2
from S-4/A 21 pages Annex F Bylaws of Oncothyreon Inc
12/34/56
EX-3.1
from S-4/A 8 pages Annex E Amended and Restated Certificate of Incorporation of Biomira Corporation Biomira Corporation a Delaware Corporation By: /S/ Robert L. Kirkman Robert L. Kirkman, President and Chief Executive Officer E-1
12/34/56
EX-3.2
from S-4 21 pages Annex F Bylaws of Biomira Corporation
12/34/56
EX-3.1
from S-4 8 pages Annex E Amended and Restated Certificate of Incorporation of Biomira Corporation Biomira Corporation a Delaware Corporation By: /S/ Effie Toshav Effie Toshav Sole Incorporator E-1
12/34/56